Review Article
Availability, Pharmaceutics, Security, Pharmacokinetics, and Pharmacological Activities of Patchouli Alcohol
Table 1
The list of antimicrobial and insecticidal activity of PA.
| Numbers | Tested mode | Tested subject | Parameters (MIC/IC50/LD50/MLC) | References |
| Bacteria |
| 1 | In vitro | E. coli | MIC = 1.0 mg/mL | [29] | 2 | In vitro | P. aeruginosa | MIC = 3.5 mg/mL | [29] | 3 | In vitro | B. proteus | MIC = 3.5 mg/mL | [29] | 4 | In vitro | S. dysenteriae | MIC = 3.0 mg/mL | [29] | 5 | In vitro | T. bacillus | MIC = 6.5 mg/mL | [29] | 6 | In vitro | S. aureus | MIC = 2.0 mg/mL | [29] | 7 | In vitro | H. pylori | MIC = 78 μg/mL | [30] |
| Viruses |
| 8 | In vitro | A/PR/8/34 (H1N1) | IC50 = 2.635 μM | [31] | 9 | In vitro | B/Ibaraki/2/85 | IC50 = 40.82 μM | [31] | 10 | In vivo | A/Leningrad/134/17/1957 (H2N2) infection mice | — | [32] | 11 | In vitro | A/Leningrad/134/17/1957 (H2N2) | IC50 = 4.03 μM | [32] | 12 | In vivo | A/FM1/1/47 (H1N1) infection mice | — | [33] | 13 | In vitro | A/FM1/1/47 (H1N1) infection 16HBE | — | [34] |
| Fungus |
| 14 | In vitro | A. flavus (3.2758) | — | [35] | 15 | In vitro | A. flavus (3.4408) | — | [35] | 16 | In vitro | Aspergillus oryzae | — | [35] |
| Termite |
| 17 | In vivo | Coptotermes formosanus Shiraki | LD50 = 4.57 μg/termite | [36] |
| Mosquitoes |
| 18 | In vivo | Ae. aegypti | — | [37] | 19 | In vivo | An. stephensi | — | [37] | 20 | In vivo | Cx. quinquefasciatus | — | [37] |
| Trypanosoma |
| 21 | In vivo | Trypanosoma cruzi | MLC > 200 μM | [38] |
|
|
MIC, minimal inhibition concentration; IC50, 50% of lethal concentration; LD50, 50% of lethal dose; MLC, minimal lethal concentration.
|